Science Explorer Back to mapMap
Discussion
Researcher · Assuta Medical Center · Israel

Tal Brosh‐Nissimov

Tal Brosh‐Nissimov publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies and Vaccine Coverage and Hesitancy.

ORCID 0000-0001-7154-2032 OpenAlex
World rank
#1,103,759
of 7,710,434 ranked researchers
Rank in Israel
#7,786
of 38,292
Works
96
Citations
3.8k
Citations per work
39.8
h-index
25
i10-index 46Top 16% in Infectious Diseases
Tal Brosh‐Nissimov

What does Tal Brosh‐Nissimov research?

Tal Brosh‐Nissimov's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (3%).

Health Sciences: 45 works · 47.3% of their workMedicine: 45 works · 47.3% of their workInfectious Diseases: 25 works · 26.4% of their workEpidemiology: 13 works · 13.9% of their workSurgery: 4 works · 3.7% of their workPublic Health, Environmental and Occupational Health: 3 works · 3.3% of their workEverything else: 44 works · 45.7% of their workLife Sciences: 7 works · 7.0% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 3.7% of their workMolecular Biology: 4 works · 3.7% of their workImmunology and Microbiology: 3 works · 3.3% of their workImmunology: 3 works · 3.3% of their workTHEIR WORKTalBrosh‐Nissimov96works
Life Sciences7%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4547.3%
  2. Everything else4445.7%
    1. Biochemistry, Genetics and Molecular Biology43.7%
    2. Immunology and Microbiology33.3%
  1. 1Infectious Diseases26% of their works
  2. 2Epidemiology14% of their works
  3. 3Surgery4% of their works
  4. 4Molecular Biology4% of their works
  5. 5Immunology3% of their works
  6. 6Public Health, Environmental and Occupational Health3% of their works

Research topics

Which keywords describe Tal Brosh‐Nissimov's research?

The keywords of their largest research topics: Pandemic, SARS-CoV-2, ACE2 Receptor, Epidemiology, Coronavirus, Vaccine, Clinical Characteristics and Thrombosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Pandemic453 topics
  2. SARS-CoV-2443 topics
  3. ACE2 Receptor392 topics
  4. Epidemiology354 topics
  5. Coronavirus211 topic
  6. Vaccine211 topic
  7. Clinical Characteristics181 topic
  8. Thrombosis181 topic
  9. COVID-19112 topics
  10. COVID-19 Vaccine81 topic
  11. Vaccine Hesitancy81 topic
  12. Cancer61 topic
  13. Human Metapneumovirus61 topic
  14. MRSA61 topic
  15. Mortality61 topic
  16. Respiratory Syncytial Virus61 topic
  17. Staphylococcus aureus61 topic
  18. Candidiasis51 topic
  19. Invasive Fungal Infections51 topic
  20. Pregnancy51 topic
  21. Vertical Transmission51 topic

Where does Tal Brosh‐Nissimov work?

Tal Brosh‐Nissimov's main affiliation in the publication record is Assuta Medical Center, Israel.

How many publications and citations does Tal Brosh‐Nissimov have?

OpenAlex counts 96 works and 3,816 citations for Tal Brosh‐Nissimov, an h-index of 25, ranking #1,103,759 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tal Brosh‐Nissimov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.